HELX

Franklin Genomic Advancements ETF

Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life.

  • Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine
  • Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment
  • Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation

MANAGEMENT

Matthew Moberg

  • California, United States
  • Years With Firm: 20
  • Years Of Experience: 22

Joyce Lin, CFA®

  • California, United States
  • Years With Firm: 5
  • Years Of Experience: 9